Universal Beteiligungs und Servicegesellschaft mbH Grows Position in STERIS plc $STE

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH increased its stake in STERIS by 26.2% in Q4 to 72,230 shares, worth about $18.33 million (roughly 0.07% of the company).
• STERIS reported Q earnings of $2.53 per share (meeting estimates) with revenue up 9.2% year‑over‑year and set FY2026 guidance of 10.15–10.30 EPS (sell‑side consensus 10.22).
• Institutional investors hold 94.69% of the stock, analysts have a consensus rating of "Moderate Buy" with a $275.20 price target, and the company pays a $0.63 quarterly dividend (1.1% yield).

Universal Beteiligungs und Servicegesellschaft mbH grew its stake in shares of STERIS plc (NYSE:STE - Free Report) by 26.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 72,230 shares of the medical equipment provider's stock after buying an additional 15,012 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned 0.07% of STERIS worth $18,327,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. OVERSEA CHINESE BANKING Corp Ltd bought a new stake in shares of STERIS during the fourth quarter valued at about $236,000. Evergreen Capital Management LLC increased its position in shares of STERIS by 8.6% during the fourth quarter. Evergreen Capital Management LLC now owns 994 shares of the medical equipment provider's stock valued at $252,000 after buying an additional 79 shares during the period. Revisor Wealth Management LLC increased its position in shares of STERIS by 11.1% during the fourth quarter. Revisor Wealth Management LLC now owns 1,000 shares of the medical equipment provider's stock valued at $260,000 after buying an additional 100 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of STERIS by 160.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 63,990 shares of the medical equipment provider's stock valued at $16,223,000 after buying an additional 39,395 shares during the period. Finally, Krilogy Financial LLC increased its position in shares of STERIS by 5.3% during the fourth quarter. Krilogy Financial LLC now owns 5,102 shares of the medical equipment provider's stock valued at $1,342,000 after buying an additional 255 shares during the period. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Down 0.7%

STE stock opened at $221.86 on Friday. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. The company's 50 day moving average is $228.82 and its 200 day moving average is $245.30. The stock has a market cap of $21.76 billion, a price-to-earnings ratio of 30.94 and a beta of 1.07. STERIS plc has a 1-year low of $209.98 and a 1-year high of $269.44.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The business's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Sell-side analysts predict that STERIS plc will post 10.22 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were given a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Tuesday, February 17th. STERIS's dividend payout ratio is 35.15%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on STE shares. Weiss Ratings cut STERIS from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Thursday, April 16th. Wall Street Zen upgraded STERIS from a "buy" rating to a "strong-buy" rating in a research report on Saturday, April 18th. Five analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, STERIS currently has a consensus rating of "Moderate Buy" and a consensus price target of $275.20.

Insider Buying and Selling at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the company's stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the transaction, the director directly owned 705 shares in the company, valued at approximately $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.07% of the company's stock.

STERIS Company Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.